Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 6, 2003 - Issue 4
83
Views
16
CrossRef citations to date
0
Altmetric
Articles

A Comparison of Tyrosine against Placebo, Phentermine, Caffeine, and d-Amphetamine During Sleep Deprivation

Pages 221-235 | Published online: 05 Sep 2013

References

  • Banderet, L.E. and Lieberman, H.R. (1989 ) “Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans”, Brain Research Bulletin 22, 759–62.
  • Beaumont, M., Batejat, D., Pierard, C., Coste, O., Doireau, P., Van Beers, P., Chauffard, F., Chassard, D., Enslen, M., Denis, J.B. and Lagarde, D. (2001 ) “Slow release caffeine and prolonged (64-h) continuous wakefulness: effects on vigilance and cognitive performance”, Journal of Sleep Research 10, 265–276.
  • Bonnet, M., Carley, D. and Carskadon, M. (and Task Force) (1992 ) “ASDA Report. EEG arousals: scoring rules and examples”, Sleep 15, 173–184.
  • Carskadon, M.A., Dement, W.C., Mitler, M.M., Roth, T., Westbrook, P.R. and Keenan, S. (1986 ) “Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness”, Sleep 15, 168–176.
  • Deijen, J.B., Wientjes, C.J., Vullinghs, H.F., Cloin, P.A. and Langefeld, J.J. (1999 ) “Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course”, Brain Research Bulletin 48, 203–209.
  • De-Valck, E. and Cluydts, R. (2001 ) “Slow-release caffeine as a countermeasure to driver sleepiness induced by partial sleep deprivation”, Journal of Sleep Research 10, 203–209.
  • Dollins, A.B., Krock, L.P., Storm, W.F., Wurtman, R.J. and Lieberman, H.R. (1995 ) “L-tyrosine ameliorates some effects of lower body negative pressure stress”, Physiology and Behavior 57, 223–230.
  • Elwes, R.D., Crewes, H., Chesterman, L.P, Summers, B., Jenner, P., Binnie, C.D. and Parkes, J.D. (1989 ) “Treatment of narcolepsy with L-tyrosine: double-blind placebo-controlled trial”, Lancet 2, 1067–1069.
  • First, M.B., Gibbon, M., Spitzer, R.L. and Williams, J.B.W. (1995) User's guide for the structural clinical interview for DSM-IVAxis I Disorders (SCID-I, Version 2.0) (American Psychiatric Press, Washington, DC).
  • Kamimori, G.H., Penetar, D.M., Headley, D.B., Thorne, D.R., Otterstetter, R. and Belenky, G. (2000 ) “Effect of three caffeine doses on plasma catecholamines and alertness during prolonged wakefulness”, European Journal of Pharmacology 56, 537–544.
  • Kelly, T.L., Mitler, M.M. and Bonnet, M.H. (1997 ) “Sleep latency measures of caffeine effects during sleep deprivation”, Electroencephalography and Clinical Neurophysiology 102, 397–400.
  • Lagarde, D., Batejat, D., Sicard, B., Trocherie, S., Chassard, D., Enslen, M. and Chauffard, F. (2000 ) “Slow-release caffeine: a new response to the effects of a limited sleep deprivation”, Sleep 23, 651–661.
  • Lieberman, H.R. (1994 ) “Tyrosine and stress: Human and animal studies ”, In: Marriott, B.M., ed, Food Components to Enhance Performance (National Academy Press, Washington, DC ), pp 277–299.
  • McCann, U.D., Penetar, D.M., Shaham, Y., Thorne, D.R., Gillin, J.C., Sing, H.C., Thomas, M.A. and Belenky, G. (1992 ) “Sleep deprivation and impaired cognition. Possible role of brain catecholamines”, Biological Psychiatry 31, 1082–1097.
  • McCann, U.D., Penetar, D.M., Shaham, Y., Thorne, D.R., Sing, H.C., Thomas, M.L., Gillin, J.C. and Belenky, G. (1993 ) “Effects of catecholamine depletion on alertness and mood in rested and sleep deprived normal volunteers”, Neuropsychopharmacology 4, 345–356.
  • McCann, V.D., Thorne, D., Hall, M., Popp, K., Avery, W., Sing, H., Thomas, M. and Belerky, G. (1995 ) “The effects of L-dihydroxyphenylalanine on alertness and mood in alpha-methyl-paratyrosine-treated healthy humans. Further evidence for the role of catecholamines in arousal and anxiety”, Neuropsychopharmacology 13, 41–52.
  • Mouret, J., Lemoine, P., Sanchez, P., Robelin, N., Taillard, J. and Canini, F. (1988 ) “Treatment of narcolepsy with L-tyrosine”, Lancet 2, 1458–1459.
  • Neri, D.F., Wiegmann, D., Stanny, R.R., Shappell, S.A., McCardie, A. and McKay, D.L. (1995 ) “The effects of tyrosine on cognitive performance during extended wakefulness”, Aviation Space and Environmental Medicine 66, 313–319.
  • Newhouse, P.A., Belenky, G., Thomas, M., Thorne, D., Sing, H.C. and Fertig, J. (1989 ) “Effects of D-amphetamine on arousal, cognition, and mood after prolonged total sleep deprivation”, Neuropsychopharmacology 2, 153–164.
  • Newhouse, P.A., Penetar, D.M., Fertig, J.B., Thorne, D., Sing, H.C., Thomas, M.L., Cochran, J.C. and Belenky, G.L. (1992 ) “Stimulant drug effects on performance and behavior after prolonged sleep deprivation: a comparison of amphetamine, nicotine, and deprenyl”, Military Psychology: The Official Journal of the Division of Military Psychology, American Psychological Association 4, 207–233.
  • Nicholson, A., Bradley, C. and Pasco, P. (1994 ) “Medication effects on sleep and wakefulness ”, In: Kryger, M.H., Roth, T. and Dement, W.C., eds, Principles and Practices of Sleep Medicine, 2nd Ed. (W.B. Saunders Co., Philadelphia, PA ) pp 364–372.
  • Oswald, I., Jones, H.S. and Mannerheim, J.E. (1968 ) “Effects of two slimming drugs on sleep”, British Medical Journal 1, 796–799.
  • Penetar, D., McCann, U., Thorne, D., Kamimori, G., Galinskim, C., Sing, H., Thomas, M. and Belenky, G. (1993 ) “Caffeine reversal of sleep deprivation effects on alertness and mood”, Psychopharmacology 112, 359–365.
  • University of California, Los Angeles, Brain Information Service, NINDB Neurological Information Network (U.S.), Rechtschaffen, A. and Kales, A. (1968) A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages of Human Subjects (U.S. National Institute of Neurological Diseases and Blindness, Neurological Information Network, NIH Publication #204, Bethesda, MD ) pp 1–57.
  • Shukitt, H.B., Stillman, M.J. and Lieberman, H.R. (1996 ) “Tyrosine administration prevents hypoxia-induced decrements in learning and memory”, Physiology and Behavior 59, 867–871.
  • Shurtleff, D., Thomas, J.R., Ahlers, S.T. and Schrot, J. (1994 ) “Tyrosine reverses a cold-induced working memory deficit in humans”, Pharmacology, Biochemistry and Behavior 47, 935–941.
  • Struder, L., Meidinger, N., Stotter, D., Kemmer, J., Lechner, P., Leutenegger, P., Soltau, H., Eggert, F., Rohde, M. and Schulein, T. (1998 ) “High-resolution x-ray spectroscopy close to room temperature”, Microscopy and Microanalysis: The Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada 6, 622–631.
  • Vogel, G.W., Buffenstein, A., Minter, K. and Hennessy, A. (1990 ) “Drug effects on REM sleep and on endogenous depression”, Neuroscience and Biobehavioral Reviews 4, 49–63.
  • Wesensten, N.J., Belenky, G., Kautz, M.A., Thorne, D.R., Reichardt, R.M. and Balkin, T.J. (2002 ) “Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine”, Psychopharmacology 159, 238–247.
  • Wurtman, R.J., Hefti, F. and Melamed, E. (1981 ) “Precursor control of neurotransmitter synthesis”, Pharmacology Reviews 32, 315–335.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.